Medications for Hyperlipoproteinemia Type Iv

11 results

  • 70011405 (gemfibrozil)

    (Gemfibrozil)
    Watson Laboratories, Inc.
    Usage: Gemfibrozil is indicated as adjunctive therapy to diet for treating very high serum triglyceride levels (Types IV and V hyperlipidemia) to reduce pancreatitis risk, and for reducing coronary heart disease risk in Type IIb patients who inadequately respond to lifestyle changes and other therapies.

  • Ezetimibe (ezetimibe)

    (Ezetimibe)
    Bryant Ranch Prepack
    Usage: Ezetimibe Tablets are indicated for reducing elevated LDL-C in adults with primary hyperlipidemia, including HeFH, and in pediatric patients aged 10 and older with HeFH. It is also used for mixed hyperlipidemia, HoFH, and to lower sitosterol and campesterol levels in patients aged 9 and older.

  • Ezetimibe (ezetimibe)

    (Ezetimibe)
    Orient Pharma Co., Ltd.
    Usage: Ezetimibe is indicated for reducing elevated LDL-C in adults and pediatric patients with primary hyperlipidemia, including HeFH and HoFH, as well as in mixed hyperlipidemia. It also helps decrease elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia, as an adjunct to diet.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    Aphena Pharma Solutions - Tennessee, LLC
    Usage: Gemfibrozil is indicated as adjunctive therapy to diet for treating very high serum triglyceride levels (Types IV and V hyperlipidemia) to reduce pancreatitis risk and for lowering coronary heart disease risk in Type IIb patients with specific lipid abnormalities who inadequately respond to lifestyle and other pharmacologic interventions.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    Bryant Ranch Prepack
    Usage: Gemfibrozil tablets are indicated as adjunctive therapy to diet for treating adults with very high triglyceride levels (Types IV and V hyperlipidemia) at risk of pancreatitis, and for reducing coronary heart disease risk in Type IIb patients with inadequate responses to lifestyle changes and other medications.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    Rebel Distributors Corp
    Usage: Gemfibrozil tablets are indicated as adjunctive therapy to diet for treating very high triglyceride levels in adults at risk of pancreatitis (Types IV and V hyperlipidemia) and for reducing coronary heart disease risk in Type IIb patients unresponsive to lifestyle modifications and other agents, while not recommended for Type I or low HDL-only patients.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    NorthStar RxLLC
    Usage: Gemfibrozil tablets, USP are indicated as adjunctive therapy to diet for treating adults with very high serum triglyceride levels (Types IV and V hyperlipidemia) at risk of pancreatitis and for reducing coronary heart disease risk in Type IIb patients unresponsive to diet and other treatments.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    West-ward Pharmaceutical Corp
    Usage: Gemfibrozil Tablets are indicated as adjunct therapy to diet for adult patients with very high triglyceride levels (Types IV and V hyperlipidemia) at risk of pancreatitis and for reducing coronary heart disease risk in Type IIb patients unresponsive to lifestyle changes and other treatments.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    REMEDYREPACK INC.
    Usage: Gemfibrozil tablets are indicated as adjunctive therapy to diet for treating severe hypertriglyceridemia (Types IV and V) to reduce pancreatitis risk and for lowering coronary heart disease risk in Type IIb patients not responding to other therapies. It is not indicated for Type I hyperlipoproteinemia or low HDL-cholesterol alone.

  • Gemfibrozil (gemfibrozil)

    (Gemfibrozil)
    Dispensing Solutions, Inc.
    Usage: Gemfibrozil Tablets are indicated as adjunctive therapy to diet for treating very high serum triglyceride levels (Types IV and V) at risk of pancreatitis and for reducing coronary heart disease risk in Type IIb patients with inadequate dietary response, characterized by low HDL and high LDL/triglycerides.